UK Companies House feature
LUMIRADX UK LTD
Profile
- Company number
- 09206123
- Status
- Active
- Incorporation
- 2014-09-05
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 32500
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- UK-adopted IFRS
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements are prepared on a going concern basis as the directors have assessed the ability of the company to continue trading for a minimum period of 12 months from the date of authorising these financial statements. The directors have obtained a letter of financial support from the Company's parent entity, Roche Diagnostics Limited, and assessed the ability of the parent to provide the levels of financial assistance required to enable the company to meet its financial obligations as they fall due. Based on the above, the directors believe it is appropriate to prepare the financial statements on a going concern basis.”
Subsidiaries
- SureSensors Limited · 100% held · England · Manufacturer of medical diagnostics
Significant events
- “On 22 January 2025 the company announced the start of employee consultations, with the new organisation being announced on 31 March 2025. It was also announced that activities would commence to close the sites in Thurleigh, Scion House (2025), Manor Loan and Dumyat (2026), transferring activities and staff to create centres of excellence for manufacturing and research and development in Motherwell.”
- “On 1 April 2025 the commercialisation activities to market, distribute and service the LumiraDx point of care diagnostics equipment to the UK and Irish healthcare markets was transferred to Roche Diagnostics Limited. Also, at this date LumiraDx UK limited ceased being the central entrepreneur for the LumiraDx legal entities with future focus on manufacturing and contract research and development of LumiraDx's transformative Point of Care solution for the Roche Group.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
4 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| STYLES, Anna Claire | Secretary | 2025-06-02 | — | — |
| MARTIUS, Alexander Georg | Director | 2025-06-11 | Dec 1979 | Swiss,British |
| PEARSON, Nicholas Guy | Director | 2024-10-08 | Dec 1969 | British |
| REYNOLDS, Ross Gerard | Director | 2024-10-08 | Sep 1985 | Scottish |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| PAWAN, Catherine Sarah | Secretary | 2024-08-30 | 2024-10-08 |
| AMEYE, Veronique Yvonne | Director | 2020-07-20 | 2024-10-08 |
| DE BRUNNER, Aidan Whiteman | Director | 2023-12-28 | 2024-07-26 |
| ERWIN, Richard William | Director | 2024-07-26 | 2024-10-08 |
| KRUSE, Niklas | Director | 2024-07-26 | 2024-10-08 |
| MCALEER, Jerome Francis, Dr | Director | 2014-11-18 | 2023-11-01 |
| SCOTT, David, Dr | Director | 2014-11-18 | 2023-11-01 |
| TWIST, Geoffrey John | Director | 2024-07-26 | 2024-10-08 |
| ZWANZIGER, Ron | Director | 2014-09-05 | 2023-11-01 |
| OVAL NOMINEES LIMITED | Corporate Director | 2014-09-05 | 2014-09-05 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Roche Diagnostics Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2024-07-26 | Active |
| Lumira Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2024-07-26 |
Filing timeline
Last 20 of 103 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-01-30 | AA | accounts | accounts with accounts type full |
| 2025-10-24 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-06-11 | AP01 | officers | appoint person director company with name date |
| 2025-06-02 | AP03 | officers | appoint person secretary company with name date |
| 2024-12-04 | AA | accounts | accounts with accounts type full |
| 2024-11-11 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-10-11 | AP01 | officers | appoint person director company with name date |
| 2024-10-08 | TM01 | officers | termination director company with name termination date |
| 2024-10-08 | TM01 | officers | termination director company with name termination date |
| 2024-10-08 | AP01 | officers | appoint person director company with name date |
| 2024-10-08 | TM01 | officers | termination director company with name termination date |
| 2024-10-08 | TM01 | officers | termination director company with name termination date |
| 2024-10-08 | TM02 | officers | termination secretary company with name termination date |
| 2024-09-10 | AP03 | officers | appoint person secretary company with name date |
| 2024-08-29 | MR05 | mortgage | mortgage charge whole release with charge number |
| 2024-08-29 | MR05 | mortgage | mortgage charge whole release with charge number |
| 2024-08-12 | AP01 | officers | appoint person director company with name date |
| 2024-08-09 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2024-08-09 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2024-08-09 | CH01 | officers | change person director company with change date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory